📖 Introduction of Heartseed, Inc. 📖 (October 15, 2024)

On October 12, on TV Tokyo's show "Breakthrough," the growth stock (219A) Heartseed was introduced, so let's collaborate!

President Fukuda is an honorary professor at Keio University School of Medicine and a specialist in cardiology. He envisions simple treatment for the world's leading cause of death, heart failure, with a new treatment method on the verge of practical application‼️

🟦 New treatment for heart failure
• Create myocardial cells (top secret) from IPS cells and transplant them into the patient's heart❗
Developed a special needle (top secret) for injecting into the heart.
Developing a simple procedure of inserting a catheter from the waist without thoracotomy (top secret).

🟦 Current situation

Improvement of symptoms confirmed by myocardial cell transplantation for heart failure patients in clinical trials!
Currently conducting clinical trials of simple transplantation using a catheter!
Novo Nordisk partners! (Investment of 65.5 billion yen)

Above is it from Neko Kumamon.
(By the way, on 10/15/2024, immediately in with Heartseed! lol, wwww)